These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26896489)

  • 1. The repair capacity of lung cancer cell lines A549 and H1299 depends on HMGB1 expression level and the p53 status.
    Yusein-Myashkova S; Stoykov I; Gospodinov A; Ugrinova I; Pasheva E
    J Biochem; 2016 Jul; 160(1):37-47. PubMed ID: 26896489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMGB1 Enhances Drug Resistance and Promotes In Vivo Tumor Growth of Lung Cancer Cells.
    Zheng H; Chen JN; Yu X; Jiang P; Yuan L; Shen HS; Zhao LH; Chen PF; Yang M
    DNA Cell Biol; 2016 Oct; 35(10):622-627. PubMed ID: 27383136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Native HMGB1 protein inhibits repair of cisplatin-damaged nucleosomes in vitro.
    Ugrinova I; Zlateva S; Pashev IG; Pasheva EA
    Int J Biochem Cell Biol; 2009 Jul; 41(7):1556-62. PubMed ID: 19401149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin transiently up-regulates hHR23 expression through enhanced translational efficiency in A549 adenocarcinoma cells.
    Shen YH; Chen BR; Cherng SH; Chueh PJ; Tan X; Lin YW; Lin JC; Chuang SM
    Toxicol Lett; 2011 Sep; 205(3):341-50. PubMed ID: 21742020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
    Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
    Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs.
    Olaussen KA; Adam J; Vanhecke E; Vielh P; Pirker R; Friboulet L; Popper H; Robin A; Commo F; Thomale J; Kayitalire L; Filipits M; Le Chevalier T; André F; Brambilla E; Soria JC
    Lung Cancer; 2013 May; 80(2):216-22. PubMed ID: 23410825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-mobility group box 1-mediated matrix metalloproteinase-9 expression in non-small cell lung cancer contributes to tumor cell invasiveness.
    Liu PL; Tsai JR; Hwang JJ; Chou SH; Cheng YJ; Lin FY; Chen YL; Hung CY; Chen WC; Chen YH; Chong IW
    Am J Respir Cell Mol Biol; 2010 Nov; 43(5):530-8. PubMed ID: 19933377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. REV3L modulates cisplatin sensitivity of non-small cell lung cancer H1299 cells.
    Wang W; Sheng W; Yu C; Cao J; Zhou J; Wu J; Zhang H; Zhang S
    Oncol Rep; 2015 Sep; 34(3):1460-8. PubMed ID: 26165320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-ray irradiation altered chemosensitivity of a p53-null non-small cell lung cancer cell line.
    Tsutsumi K; Yasuda M; Nishioka T
    Cell Struct Funct; 2006; 31(2):47-52. PubMed ID: 16951535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox state-dependent interaction of HMGB1 and cisplatin-modified DNA.
    Park S; Lippard SJ
    Biochemistry; 2011 Apr; 50(13):2567-74. PubMed ID: 21355578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage.
    Krynetskaia NF; Phadke MS; Jadhav SH; Krynetskiy EY
    Mol Cancer Ther; 2009 Apr; 8(4):864-72. PubMed ID: 19372559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
    Katiyar SK; Meeran SM; Katiyar N; Akhtar S
    Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced induction of Bax gene expression in H460 and H1299 cells with the combined treatment of cisplatin and adenovirus mediated wt-p53 gene transfer.
    Choi JH; Ahn KS; Kim J; Hong YS
    Exp Mol Med; 2000 Mar; 32(1):23-8. PubMed ID: 10762058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-histone protein HMGB1 inhibits the repair of damaged DNA by cisplatin in NIH-3T3 murine fibroblasts.
    Yusein-Myashkova S; Ugrinova I; Pasheva E
    BMB Rep; 2016 Feb; 49(2):99-104. PubMed ID: 24325815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
    Hu Z; Zeng Q; Zhang B; Liu H; Wang W
    Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53-dependent global nucleotide excision repair of cisplatin-induced intrastrand cross links in human cells.
    Bhana S; Hewer A; Phillips DH; Lloyd DR
    Mutagenesis; 2008 Mar; 23(2):131-6. PubMed ID: 18267949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin-induced chemosensitization to cisplatin depends on P53 status and is inhibited by Jarid1b overexpression in non-small cell lung cancer cells.
    Tortelli TC; Tamura RE; de Souza Junqueira M; da Silva Mororó J; Bustos SO; Natalino RJM; Russell S; Désaubry L; Strauss BE; Chammas R
    Aging (Albany NY); 2021 Sep; 13(18):21914-21940. PubMed ID: 34528900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenite enhances the benzo[a]pyrene diol epoxide (BPDE)-induced mutagenesis with no marked effect on repair of BPDE-DNA adducts in human lung cells.
    Chiang HC; Tsou TC
    Toxicol In Vitro; 2009 Aug; 23(5):897-905. PubMed ID: 19470404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous development of drug resistance: mismatch repair and p53 defects in resistance to cisplatin in human tumor cells.
    Branch P; Masson M; Aquilina G; Bignami M; Karran P
    Oncogene; 2000 Jun; 19(28):3138-45. PubMed ID: 10918568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of REV3L promotes p53-regulated cancer cell metabolism in cisplatin-treated lung carcinoma cells.
    Kong L; Murata MM; Digman MA
    Biochem Biophys Res Commun; 2018 Jan; 496(1):199-204. PubMed ID: 29307819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.